Literature DB >> 20739356

Diabetes and cancer.

T A Chowdhury1.   

Abstract

Diabetes and cancer are common conditions, and their co-diagnosis in the same individual is not infrequent. A link between the two conditions has been postulated for almost 80 years, but only in the past decade has significant epidemiological evidence been amassed to suggest that diabetes and cancer are associated, and the link appears causal. Hyperinsulinaemia, adipocytokines, growth factors and epigenetic changes may be implicated in the pathogenesis of cancer amongst patients with diabetes, and recently, diabetes therapies have also been implicated. There is reasonable circumstantial evidence that metformin may decrease the risk of cancer amongst diabetic patients. Much more research is required to elucidate the link between diabetes and cancer, particularly the potential link with diabetes treatments.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739356     DOI: 10.1093/qjmed/hcq149

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  28 in total

1.  Dispersal evolution in neoplasms: the role of disregulated metabolism in the evolution of cell motility.

Authors:  C Athena Aktipis; Carlo C Maley; John W Pepper
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-19

2.  Reactive-oxygen-species-mediated Cdc25C degradation results in differential antiproliferative activities of vanadate, tungstate, and molybdate in the PC-3 human prostate cancer cell line.

Authors:  Tong-Tong Liu; Yan-Jun Liu; Qin Wang; Xiao-Gai Yang; Kui Wang
Journal:  J Biol Inorg Chem       Date:  2011-10-20       Impact factor: 3.358

3.  Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.

Authors:  Arron Sikka; Manjinder Kaur; Chapla Agarwal; Gagan Deep; Rajesh Agarwal
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

4.  Diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan.

Authors:  Yu-Lung Chen; Kao-Chi Cheng; Shih-Wei Lai; I-Ju Tsai; Che-Chen Lin; Fung-Chang Sung; Cheng-Chieh Lin; Pei-Chun Chen
Journal:  Gastric Cancer       Date:  2012-10-05       Impact factor: 7.370

Review 5.  Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers.

Authors:  Bin Bao; Asfar S Azmi; Shadan Ali; Feras Zaiem; Fazlul H Sarkar
Journal:  Ann Transl Med       Date:  2014-06

Review 6.  Diabetes and cancer I: risk, survival, and implications for screening.

Authors:  Adedayo A Onitilo; Jessica M Engel; Ingrid Glurich; Rachel V Stankowski; Gail M Williams; Suhail A Doi
Journal:  Cancer Causes Control       Date:  2012-05-03       Impact factor: 2.506

7.  Diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic links.

Authors:  Valerio Gristina; Maria Grazia Cupri; Martina Torchio; Claudio Mezzogori; Laura Cacciabue; Marco Danova
Journal:  Biomed Rep       Date:  2014-12-10

Review 8.  Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.

Authors:  Adedayo A Onitilo; Jessica M Engel; Ingrid Glurich; Rachel V Stankowski; Gail M Williams; Suhail A Doi
Journal:  Cancer Causes Control       Date:  2012-04-25       Impact factor: 2.506

9.  Breast and prostate cancer survivors in a diabetic cohort: results from the Living with Diabetes Study.

Authors:  Adedayo A Onitilo; Maria Donald; Rachel V Stankowski; Jessica M Engel; Gail Williams; Suhail A R Doi
Journal:  Clin Med Res       Date:  2013-05-13

10.  Association Between Interleukin-1A, Interleukin-1B, and Bridging integrator 1 Polymorphisms and Alzheimer's Disease: a standard and Cumulative Meta-analysis.

Authors:  Xiaoliu Dong; Li Zhang; Qingling Meng; Qiuyan Gao
Journal:  Mol Neurobiol       Date:  2016-01-15       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.